Systematic review and meta-analysis of radiotherapy in various head and neck cancers: Comparing photons, carbon-ions and protons

Cancer Treatment Reviews

Volumn 37, Issue 3, 2011, Pages 185-201

  Ramaekers, Bram L T ^a   Pijls Johannesma, Madelon ^a   Joore, Manuela A ^b,c   van den Ende, Piet ^a   Langendijk, Johannes A ^d   Lambin, Philippe ^a   Kessels, Alfons G H ^c   Grutters, Janneke P C ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Carbon ion; Head and neck cancer; IMRT; Meta analysis; Particle; Photon; Proton; Radiotherapy; Systematic review

Indexed keywords

CARBON; PROTON;

ADENOID CYSTIC CARCINOMA; CANCER CONTROL; CANCER SURVIVAL; CLINICAL STUDY; COMPARATIVE STUDY; COMPUTER MODEL; DRY EYE; DYSPHAGIA; HEAD AND NECK CANCER; HUMAN; ION THERAPY; META ANALYSIS; MOUTH CANCER; NASOPHARYNX CARCINOMA; NOSE CANCER; OPTIC NERVE DISEASE; OROPHARYNX CARCINOMA; PHOTON THERAPY; PROTON THERAPY; RADIATION DOSE; REVIEW; SKIN TOXICITY; VISUAL IMPAIRMENT; XEROSTOMIA;

CARBON; HEAD AND NECK NEOPLASMS; HUMANS; IONS; PHOTONS; PROTONS; RADIOTHERAPY;

EID: 79952008058     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2010.08.004     Document Type: Review

References (139)

1. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007, 18:581-592.
2. Baujat B., Audry H., Bourhis J., et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 2006, 64:47-56.
3. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006, 368:843-854.
4. Pignon J.P., le Maitre A., Maillard E., Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients. Radiother Oncol 2009, 92:4-14.
5. Duke R.L., Campbell B.H., Indresano A.T., et al. Dental status and quality of life in long-term head and neck cancer survivors. Laryngoscope 2005, 115:678-683.
6. Hammerlid E., Silander E., Hornestam L., Sullivan M. Health-related quality of life three years after diagnosis of head and neck cancer - a longitudinal study. Head Neck 2001, 23:113-125.
7. Jensen A.B., Hansen O., Jorgensen K., Bastholt L. Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer. Acta Oncol 1994, 33:487-491.
8. Langendijk J.A., Doornaert P., Verdonck-de Leeuw I.M., Leemans C.R., Aaronson N.K., Slotman B.J. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 2008, 26:3770-3776.
9. List M.A., Bilir S.P. Functional outcomes in head and neck cancer. Semin Radiat Oncol 2004, 14:178-189.
10. Durante M., Loeffler J.S. Charged particles in radiation oncology. Nat Rev Clin Oncol 2010, 7:37-43.
11. Glimelius B., Ask A., Bjelkengren G., et al. Number of patients potentially eligible for proton therapy. Acta Oncol 2005, 44:836-849.
12. Palm A., Johansson K.A. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors. Acta Oncol 2007, 46:462-473.
13. Brada M., Pijls-Johannesma M., De Ruysscher D. Proton therapy in clinical practice: current clinical evidence. J Clin Oncol 2007, 25:965-970.
14. Jereczek-Fossa B.A., Krengli M., Orecchia R. Particle beam radiotherapy for head and neck tumors: radiobiological basis and clinical experience. Head Neck 2006, 28:750-760.
15. Lodge M., Pijls-Johannesma M., Stirk L., Munro A.J., De Ruysscher D., Jefferson T. A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer. Radiother Oncol 2007, 83:110-122.
16. Chan A.W., Liebsch N.J. Proton radiation therapy for head and neck cancer. J Surg Oncol 2008, 97:697-700.
17. Ask A., Bjork-Eriksson T., Zackrisson B., Blomquist E., Glimelius B. The potential of proton beam radiation therapy in head and neck cancer. Acta Oncol 2005, 44:876-880.
18. Schulz-Ertner D., Jakel O., Schlegel W. Radiation therapy with charged particles. Semin Radiat Oncol 2006, 16:249-259.
19. Schulz-Ertner D., Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 2007, 25:953-964.
20. Brada M., Pijls-Johannesma M., De Ruysscher D. Current clinical evidence for proton therapy. Cancer J 2009, 15:319-324.
21. Pijls-Johannesma M., Pommier P., Lievens Y. Cost-effectiveness of particle therapy: current evidence and future needs. Radiother Oncol 2008, 89:127-134.
22. Glimelius B., Isacsson U., Blomquist E., Grusell E., Jung B., Montelius A. Potential gains using high-energy protons for therapy of malignant tumours. Acta Oncol 1999, 38:137-145.
23. Richardson W.S., Wilson M.C., Nishikawa J., Hayward R.S. The well-built clinical question: a key to evidence-based decisions. ACP J Club 1995, 123:A12-A13.
24. Feuvret L., Noel G., Mazeron J.J., Bey P. Conformity index: a review. Int J Radiat Oncol Biol Phys 2006, 64:333-342.
25. Mayo C., Martel M.K., Marks L.B., Flickinger J., Nam J., Kirkpatrick J. Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys 2010, 76:S28-S35.
26. Deasy J.O., Moiseenko V., Marks L., Chao K.S., Nam J., Eisbruch A. Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 2010, 76:S58-S63.
27. Caudell J.J., Burnett O.L., Schaner P.E., Bonner J.A., Duan J. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer. Int J Radiat Oncol Biol Phys 2010, 77:462-467.
28. Rancati T., Schwarz M., Allen A.M., et al. Radiation dose-volume effects in the larynx and pharynx. Int J Radiat Oncol Biol Phys 2010, 76:S64-S69.
29. Moore D.S., McCabe G.P., Craig B.A. Introduction to the practice of statistics 2009, W.H. Freeman Company. 6th ed.
30. Cantor A.B. Projecting the standard error of the Kaplan-Meier estimator. Stat Med 2001, 20:2091-2097.
31. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II analysis and examples. Br Journal of Cancer 1973, 35:1-39.
32. Thompson S.G., Higgins J.P. How should meta-regression analyses be undertaken and interpreted?. Stat Med 2002, 21:1559-1573.
33. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
34. Mizoe JE, Hasegawa A, Bessho H, Jingu K, Kakimoto Y. Head and neck tumors. In: Proceedings of NIRS-ETOILE: joint symposium 2009 on carbon ion radiotherapy. Lyon; 2009.
35. Mizoe J.E., Tsujii H., Kamada T., et al. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004, 60:358-364.
36. Tokuuye K., Akine Y., Kagei K., et al. Proton therapy for head and neck malignancies at Tsukuba. Strahlenther Onkol 2004, 180:96-101.
37. Milano M.T., Vokes E.E., Kao J., et al. Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions. Int J Oncol 2006, 28:1141-1151.
38. Monroe A.T., Young J.A., Huff J.D., Ernster J.A., White G.A., Peddada A.V. Accelerated fractionation head and neck intensity-modulated radiation therapy and concurrent chemotherapy in the community setting: safety and efficacy considerations. Head Neck 2009, 31:1144-1151.
39. Rades D., Fehlauer F., Wroblesky J., Albers D., Schild S.E., Schmidt R. Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy. Oral Oncol 2007, 43:535-543.
40. Studer G., Furrer K., Davis B.J., et al. Postoperative IMRT in head and neck cancer. Radiat Oncol 2006, 1:40.
41. Seung S., Bae J., Solhjem M., et al. Intensity-modulated radiotherapy for head-and-neck cancer in the community setting. Int J Radiat Oncol Biol Phys 2008, 72:1075-1081.
42. Lauve A., Morris M., Schmidt-Ullrich R., et al. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II - clinical results. Int J Radiat Oncol Biol Phys 2004, 60:374-387.
43. Nangia S, Chufal KS, Tyagi A, Bhatnagar A, Mishra M, Ghosh D. Selective nodal irradiation for head and neck cancer using intensity-modulated radiotherapy: application of RTOG consensus guidelines in routine clinical practice. Int J Radiat Oncol Biol Phys; 2009.
44. Saba N.F., Edelman S., Tighiouart M., et al. Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: a retrospective single-institution analysis. Head Neck 2009, 31:1447-1455.
45. Chan A.W., Liebsch L.J., Deschler D.G., et al. Proton radiotherapy for T4 nasopharyngeal carcinoma. J Clin Oncol (Meeting Abstracts) 2004, 22:5574.
46. Chong Z. Improved local control with intensity modulated radiation therapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2004, 60:S317.
47. Fang F.M., Chien C.Y., Tsai W.L., et al. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy - a longitudinal study. Int J Radiat Oncol Biol Phys 2008, 72:356-364.
48. Kam M.K., Teo P.M., Chau R.M., et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2004, 60:1440-1450.
49. Kim K., Wu H.G., Kim H.J., et al. Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Head Neck 2009, 31:1121-1128.
50. Koom W.S., Kim T.H., Shin K.H., et al. SMART (simultaneous modulated accelerated radiotherapy) for locally advanced nasopharyngeal carcinomas. Head Neck 2008, 30:159-169.
51. Kwong D.L., Pow E.H., Sham J.S., et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer 2004, 101:1584-1593.
52. Lee N., Harris J., Garden A.S., et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009, 27:3684-3690.
53. Lee N., Xia P., Quivey J.M., et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002, 53:12-22.
54. Lin S., Pan J., Han L., Zhang X., Liao X., Lu J.J. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys 2009, 75:1071-1078.
55. Nishimura Y., Shibata T., Nakamatsu K., et al. A two-step intensity-modulated radiation therapy method for nasopharyngeal cancer: the Kinki University experience. Jpn J Clin Oncol 2009, 40:130-138.
56. Tham I.W., Hee S.W., Yeo R.M., et al. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy - The National Cancer Centre Singapore experience. Int J Radiat Oncol Biol Phys 2009, 75:1481-1486.
57. Wolden S.L., Chen W.C., Pfister D.G., Kraus D.H., Berry S.L., Zelefsky M.J. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 2006, 64:57-62.
58. Wong F.C., Ng A.W., Lee V.H., et al. Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2009, 76:138-145.
59. Zheng J, Wang G, Yang GY, et al. Induction chemotherapy with nedaplatin with 5-FU followed by intensity-modulated radiotherapy concurrent with chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Jpn J Clin Oncol 2010 [Epub ahead of print].
60. Slater J.D., Yonemoto L.T., Mantik D.W., et al. Proton radiation for treatment of cancer of the oropharynx: early experience at Loma Linda University Medical Center using a concomitant boost technique. Int J Radiat Oncol Biol Phys 2005, 62:494-500.
61. Chao K.S., Ozyigit G., Blanco A.I., et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Radiat Oncol Biol Phys 2004, 59:43-50.
62. Eisbruch A, Harris J, Garden AS, et al. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys 2009.
63. Garden A.S., Morrison W.H., Wong P.F., et al. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2007, 67:438-444.
64. Huang K., Lee N., Xia P., et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal carcinoma: a single institutional experience. Int J Radiat Oncol Biol Phys 2003, 57:S302.
65. Lawson J.D., Otto K., Chen A., Shin D.M., Davis L., Johnstone P.A. Concurrent platinum-based chemotherapy and simultaneous modulated accelerated radiation therapy for locally advanced squamous cell carcinoma of the tongue base. Head Neck 2008, 30:327-335.
66. Lee N.Y., de Arruda F.F., Puri D.R., et al. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006, 66:966-974.
67. Rusthoven K.E., Raben D., Ballonoff A., Kane M., Song J.I., Chen C. Effect of radiation techniques in treatment of oropharynx cancer. Laryngoscope 2008, 118:635-639.
68. Schoenfeld G.O., Amdur R.J., Morris C.G., Li J.G., Hinerman R.W., Mendenhall W.M. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008, 71:377-385.
69. Yao M., Nguyen T., Buatti J.M., et al. Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research. Am J Clin Oncol 2006, 29:606-612.
70. Daly M.E., Le Q.T., Maxim P.G., et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 2010, 76:1339-1346.
71. Nishimura H., Ogino T., Kawashima M., et al. Proton-beam therapy for olfactory neuroblastoma. Int J Radiat Oncol Biol Phys 2007, 68:758-762.
72. Resto V.A., Chan A.W., Deschler D.G., Lin D.T. Extent of surgery in the management of locally advanced sinonasal malignancies. Head Neck 2008, 30:222-229.
73. Daly M.E., Chen A.M., Bucci M.K., et al. Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys 2007, 67:151-157.
74. Madani I., Bonte K., Vakaet L., Boterberg T., De Neve W. Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update. Int J Radiat Oncol Biol Phys 2009, 73:424-432.
75. Weber D.C., Chan A.W., Lessell S., et al. Visual outcome of accelerated fractionated radiation for advanced sinonasal malignancies employing photons/protons. Radiother Oncol 2006, 81:243-249.
76. Mizoe JE, Hasegawa A, Bessho H, Jingu K, Kakimoto Y. Phase II clinical trial for mucosal malignant melanoma of the head and neck combined with chemotherapy (protocol 0007). In: Proceedings of NIRS-ETOILE: joint symposium 2009 on carbon ion radiotherapy. Lyon; 2009.
77. Andersen L.J., Berthelsen A., Hansen H.S. Malignant melanoma of the upper respiratory tract and the oral cavity. J Otolaryngol 1992, 21:180-185.
78. Bridger A.G., Smee D., Baldwin M.A., Kwok B., Bridger G.P. Experience with mucosal melanoma of the nose and paranasal sinuses. ANZ J Surg 2005, 75:192-197.
79. Gilligan D., Slevin N.J. Radical radiotherapy for 28 cases of mucosal melanoma in the nasal cavity and sinuses. Br J Radiol 1991, 64:1147-1150.
80. Guzzo M., Grandi C., Licitra L., Podrecca S., Cascinelli N., Molinari R. Mucosal malignant melanoma of head and neck: forty-eight cases treated at Istituto Nazionale Tumori of Milan. Eur J Surg Oncol 1993, 19:316-319.
81. Huang S.F., Liao C.T., Kan C.R., Chen I.H. Primary mucosal melanoma of the nasal cavity and paranasal sinuses: 12 years of experience. J Otolaryngol 2007, 36:124-129.
82. Kingdom T.T., Kaplan M.J. Mucosal melanoma of the nasal cavity and paranasal sinuses. Head Neck 1995, 17:184-189.
83. Krengli M., Masini L., Kaanders J.H., et al. Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases. A Rare Cancer Network study. Int J Radiat Oncol Biol Phys 2006, 65:751-759.
84. Loree T.R., Mullins A.P., Spellman J., North J.H., Hicks W.L. Head and neck mucosal melanoma: a 32-year review. Ear Nose Throat J 1999, 78:372-375.
85. Lund V.J., Howard D.J., Harding L., Wei W.I. Management options and survival in malignant melanoma of the sinonasal mucosa. Laryngoscope 1999, 109:208-211.
86. Manolidis S., Donald P.J. Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients. Cancer 1997, 80:1373-1386.
87. Meleti M., Leemans C.R., de Bree R., Vescovi P., Sesenna E., van der Waal I. Head and neck mucosal melanoma: experience with 42 patients, with emphasis on the role of postoperative radiotherapy. Head Neck 2008, 30:1543-1551.
88. Nakashima J.P., Viegas C.M., Fassizoli A.L., et al. Postoperative adjuvant radiation therapy in the treatment of primary head and neck mucosal melanomas. ORL J Otorhinolaryngol Relat Spec 2008, 70:344-351.
89. Owens J.M., Roberts D.B., Myers J.N. The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg 2003, 129:864-868.
90. Patel S.G., Prasad M.L., Escrig M., et al. Primary mucosal malignant melanoma of the head and neck. Head Neck 2002, 24:247-257.
91. Shibuya H., Takeda M., Matsumoto S., Hoshina M., Suzuki S., Takagi M. The efficacy of radiation therapy for a malignant melanoma in the mucosa of the upper jaw: an analytic study. Int J Radiat Oncol Biol Phys 1993, 25:35-39.
92. Temam S., Mamelle G., Marandas P., et al. Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer 2005, 103:313-319.
93. Wagner M., Morris C.G., Werning J.W., Mendenhall W.M. Mucosal melanoma of the head and neck. Am J Clin Oncol 2008, 31:43-48.
94. Yii N.W., Eisen T., Nicolson M., et al. Mucosal malignant melanoma of the head and neck: the Marsden experience over half a century. Clin Oncol (R Coll Radiol) 2003, 15:199-204.
95. Yanagi T., Mizoe J.E., Hasegawa A., et al. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 2009, 74:15-20.
96. Schulz-Ertner D., Nikoghosyan A., Didinger B., et al. Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer 2005, 104:338-344.
97. Munter M, Umathum V, Nikoghosyan A, et al. Combination of intensity modulated radiation therapy (IMRT) and a carbon ion boost for subtotal resected or inoperable adenoid cystic carcinomas (ACC's) of the head and neck region. Heidelberg; 2009 [PTCOG 48].
98. Pommier P., Liebsch N.J., Deschler D.G., et al. Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg 2006, 132:1242-1249.
99. Agarwal J.P., Jain S., Gupta T., et al. Intraoral adenoid cystic carcinoma: prognostic factors and outcome. Oral Oncol 2008, 44:986-993.
100. Avery C.M., Moody A.B., McKinna F.E., Taylor J., Henk J.M., Langdon J.D. Combined treatment of adenoid cystic carcinoma of the salivary glands. Int J Oral Maxillofac Surg 2000, 29:277-279.
101. Bhattacharyya N., Fried M.P. Determinants of survival in parotid gland carcinoma: a population-based study. Am J Otolaryngol 2005, 26:39-44.
102. Da Cruz Perez D.E., Pires F.R., Lopes M.A., de Almeida O.P., Kowalski L.P. Adenoid cystic carcinoma and mucoepidermoid carcinoma of the maxillary sinus: report of a 44-year experience of 25 cases from a single institution. J Oral Maxillofac Surg 2006, 64:1592-1597.
103. Garden A.S., Weber R.S., Morrison W.H., Ang K.K., Peters L.J. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys 1995, 32:619-626.
104. Gomez D.R., Hoppe B.S., Wolden S.L., et al. Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience. Int J Radiat Oncol Biol Phys 2008, 70:1365-1372.
105. Gurney T.A., Eisele D.W., Weinberg V., Shin E., Lee N. Adenoid cystic carcinoma of the major salivary glands treated with surgery and radiation. Laryngoscope 2005, 115:1278-1282.
106. Harbo G., Bundgaard T., Pedersen D., Sogaard H., Overgaard J. Prognostic indicators for malignant tumours of the parotid gland. Clin Otolaryngol Allied Sci 2002, 27:512-516.
107. Hosokawa Y., Ohmori K., Kaneko M., et al. Analysis of adenoid cystic carcinoma treated by radiotherapy. Oral Surg Oral Med Oral Pathol 1992, 74:251-255.
108. Hsu H.C., Huang E.Y., Wang C.J. Postoperative adjuvant radiotherapy for adenoid cystic carcinoma of the head and neck: treatment results and prognostic factors. Chang Gung Med J 2003, 26:646-653.
109. Huber P.E., Debus J., Latz D., et al. Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam?. Radiother Oncol 2001, 59:161-167.
110. Iseli T.A., Karnell L.H., Graham S.M., et al. Role of radiotherapy in adenoid cystic carcinoma of the head and neck. J Laryngol Otol 2009, 1-8.
111. Khan A.J., DiGiovanna M.P., Ross D.A., et al. Adenoid cystic carcinoma: a retrospective clinical review. Int J Cancer 2001, 96:149-158.
112. Kokemueller H., Eckardt A., Brachvogel P., Hausamen J.E. Adenoid cystic carcinoma of the head and neck - a 20 years experience. Int J Oral Maxillofac Surg 2004, 33:25-31.
113. Leonetti J.P., Marzo S.J., Agarwal N. Adenoid cystic carcinoma of the parotid gland with temporal bone invasion. Otol Neurotol 2008, 29:545-548.
114. Mendenhall W.M., Morris C.G., Amdur R.J., Werning J.W., Hinerman R.W., Villaret D.B. Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck 2004, 26:154-162.
115. Rapidis A.D., Givalos N., Gakiopoulou H., et al. Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature. Oral Oncol 2005, 41:328-335.
116. Rhee C.S., Won T.B., Lee C.H., et al. Adenoid cystic carcinoma of the sinonasal tract: treatment results. Laryngoscope 2006, 116:982-986.
117. Silverman D.A., Carlson T.P., Khuntia D., Bergstrom R.T., Saxton J., Esclamado R.M. Role for postoperative radiation therapy in adenoid cystic carcinoma of the head and neck. Laryngoscope 2004, 114:1194-1199.
118. Spiro R.H., Huvos A.G. Stage means more than grade in adenoid cystic carcinoma. Am J Surg 1992, 164:623-628.
119. Takagi D., Fukuda S., Furuta Y., et al. Clinical study of adenoid cystic carcinoma of the head and neck. Auris Nasus Larynx 2001, 28(Suppl.):S99-S102.
120. Therkildsen M.H., Christensen M., Andersen L.J., Schiodt T., Hansen H.S. Salivary gland carcinomas-prognostic factors. Acta Oncol 1998, 37:701-713.
121. Amirul Islam M., Yanagi T., Mizoe J.E., Mizuno H., Tsujii H. Comparative study of dose distribution between carbon ion radiotherapy and photon radiotherapy for head and neck tumor. Radiat Med 2008, 26:415-421.
122. Cozzi L., Fogliata A., Lomax A., Bolsi A. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. Radiother Oncol 2001, 61:287-297.
123. Johansson J., Blomquist E., Montelius A., Isacsson U., Glimelius B. Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma. Radiother Oncol 2004, 72:129-138.
124. Mock U., Georg D., Bogner J., Auberger T., Potter R. Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys 2004, 58:147-154.
125. Steneker M., Lomax A., Schneider U. Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiother Oncol 2006, 80:263-267.
126. Taheri-Kadkhoda Z., Bjork-Eriksson T., Nill S., et al. Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons. Radiat Oncol 2008, 3:4.
127. Van de Water T, Lomax A, Bijl H, et al. Comparative treatment planning study between scanned intensity modulated proton therapy and photon therapy in complex oropharyngeal carcinoma. ESTRO. Göteborg; 2008.
128. Widesott L., Pierelli A., Fiorino C., et al. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. Int J Radiat Oncol Biol Phys 2008, 72:589-596.
129. Krengli M., Jereczek-Fossa B.A., Kaanders J.H., Masini L., Beldi D., Orecchia R. What is the role of radiotherapy in the treatment of mucosal melanoma of the head and neck?. Crit Rev Oncol Hematol 2008, 65:121-128.
130. Overgaard J. The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study. Int J Radiat Oncol Biol Phys 1986, 12:867-872.
131. Blettner M., Sauerbrei W., Schlehofer B., Scheuchenpflug T., Friedenreich C. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 1999, 28:1-9.
132. National Institute for Health and Clinical Excellence (NICE). Guide to the methods of technology appraisal. London: NICE; 2008.
133. PTCOG. Statistics of patients treated in hadron therapy centers worldwide; 2009. Available from: [accessed 2009]. http://ptcog.web.psi.ch/patient_statistics.html.
134. Sayed SI, Elmiyeh B, Rhys-Evans P, et al. Quality of life and outcomes research in head and neck cancer: a review of the state of the discipline and likely future directions. Cancer Treat Rev 2009.
135. Goitein M. Trials and tribulations in charged particle radiotherapy. Radiother Oncol 2010, 95:23-31.
136. Eisbruch A., Ten Haken R.K., Kim H.M., Marsh L.H., Ship J.A. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999, 45:577-587.
137. Roesink J.M., Moerland M.A., Hoekstra A., Van Rijk P.P., Terhaard C.H. Scintigraphic assessment of early and late parotid gland function after radiotherapy for head-and-neck cancer: a prospective study of dose-volume response relationships. Int J Radiat Oncol Biol Phys 2004, 58:1451-1460.
138. Semenenko V.A., Li X.A. Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data. Phys Med Biol 2008, 53:737-755.
139. Schilstra C., Meertens H. Calculation of the uncertainty in complication probability for various dose-response models, applied to the parotid gland. Int J Radiat Oncol Biol Phys 2001, 50:147-158.